Oxitec Secures £8 Million Investment to Continue Fight Against Dengue Fever – MarketWatchPosted: February 14, 2012
Oxitec Ltd, a British company pioneering a new approach to combating dengue fever, announced today that it has secured £8 million of new investment. The investment will finance further trials of the Oxitec Control Programme, designed to reduce populations of the dengue mosquito in communities hardest hit by the disease. The Oxitec solution harnesses advanced genetics to create ‘sterile’ male insects. The company has demonstrated success in trials in a number of countries and is developing a range of products in both public health and agriculture.